Latest News and Press Releases

Dublin, May 13, 2025 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering.The global market...

Dublin, Dec. 10, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Report 2024" report has been added to ResearchAndMarkets.com's offering. This GvHD treatment...

Dublin, Nov. 07, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease (GvHD) Treatment Market Report and Forecast 2024-2032" report has been added to ResearchAndMarkets.com's offering.The graft...

New York, USA, Sept. 22, 2024 (GLOBE NEWSWIRE) -- Graft versus Host Disease Market to Increase at a CAGR of 9.9% During the Study Period (2020–2034) | DelveInsight  The graft versus host disease...

Dublin, April 12, 2024 (GLOBE NEWSWIRE) -- The "Graft Versus Host Disease Treatment Market Report: Trends, Forecast and Competitive Analysis to 2030" report has been added to ...

Dublin, Sept. 13, 2023 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market by Disease Type, Product, End-User - Cumulative Impact of COVID-19, Russia Ukraine Conflict, and...

Selbyville, Delaware, June 27, 2023 (GLOBE NEWSWIRE) -- Photopheresis Products Market size is predicted to surpass USD 488 billion by 2032. Advancements in medical technology and increasing demand...

Dublin, Aug. 30, 2022 (GLOBE NEWSWIRE) -- The "Global Graft Versus Host Disease Treatment Market (2022-2027) by Disease Type, Product, Geography, Competitive Analysis and the Impact of Covid-19 with...

Pune, India, Oct. 14, 2021 (GLOBE NEWSWIRE) -- The global “graft versus host disease treatment market” size is slated to experience a rugged expansion period on account of rising number of allogenic...

MELBOURNE, Australia and NEW YORK, Nov. 27, 2015 (GLOBE NEWSWIRE) -- Mesoblast Limited (ASX:MSB) (Nasdaq:MESO) today announced that its licensee in Japan, JCR Pharmaceuticals Co. Ltd., has received...